Shilin Xia

1.3k total citations
47 papers, 820 citations indexed

About

Shilin Xia is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Shilin Xia has authored 47 papers receiving a total of 820 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 16 papers in Surgery and 16 papers in Molecular Biology. Recurrent topics in Shilin Xia's work include Pancreatitis Pathology and Treatment (11 papers), Pancreatic and Hepatic Oncology Research (10 papers) and Ferroptosis and cancer prognosis (7 papers). Shilin Xia is often cited by papers focused on Pancreatitis Pathology and Treatment (11 papers), Pancreatic and Hepatic Oncology Research (10 papers) and Ferroptosis and cancer prognosis (7 papers). Shilin Xia collaborates with scholars based in China, Japan and United States. Shilin Xia's co-authors include Dong Shang, Hong Xiang, Xufeng Tao, Han Liu, Jialin Qu, Huiyi Song, Qi Zhou, Jianjun Liu, Xueying Shi and Fangyue Guo and has published in prestigious journals such as PLoS ONE, Scientific Reports and Cell Death and Differentiation.

In The Last Decade

Shilin Xia

46 papers receiving 817 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shilin Xia China 17 365 241 193 137 133 47 820
So‐Jin Shin South Korea 18 368 1.0× 147 0.6× 271 1.4× 140 1.0× 116 0.9× 62 1.1k
Shoichi Kado Japan 13 470 1.3× 104 0.4× 240 1.2× 111 0.8× 73 0.5× 25 889
Xufeng Guo China 16 276 0.8× 105 0.4× 135 0.7× 54 0.4× 108 0.8× 37 733
Jun Cao China 17 385 1.1× 131 0.5× 122 0.6× 66 0.5× 136 1.0× 48 823
Katarzyna Neubauer Poland 21 260 0.7× 196 0.8× 145 0.8× 221 1.6× 84 0.6× 50 975
Liang Shi China 14 257 0.7× 139 0.6× 85 0.4× 67 0.5× 177 1.3× 24 668
Jianwei Zhang China 18 184 0.5× 238 1.0× 261 1.4× 98 0.7× 87 0.7× 79 912
Zhenglei Xu China 13 261 0.7× 113 0.5× 112 0.6× 83 0.6× 162 1.2× 54 585
Shiyun Tan China 16 302 0.8× 238 1.0× 156 0.8× 125 0.9× 79 0.6× 38 933
Chung Hong Kong 18 305 0.8× 336 1.4× 72 0.4× 119 0.9× 94 0.7× 53 936

Countries citing papers authored by Shilin Xia

Since Specialization
Citations

This map shows the geographic impact of Shilin Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shilin Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shilin Xia more than expected).

Fields of papers citing papers by Shilin Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shilin Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shilin Xia. The network helps show where Shilin Xia may publish in the future.

Co-authorship network of co-authors of Shilin Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Shilin Xia. A scholar is included among the top collaborators of Shilin Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shilin Xia. Shilin Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wei, Yi, Ya Li, Shu Yin, et al.. (2024). The new anti-angiogenesis perspective of rheumatoid arthritis with geniposide: Reducing the extracellular release of HSP70 in HUVECs. International Immunopharmacology. 144. 113645–113645. 3 indexed citations
3.
4.
Chen, Xu, Qihang Yuan, Xueying Shi, et al.. (2023). Identification and characterization of interferon-γ signaling-based personalized heterogeneity and therapeutic strategies in patients with pancreatic cancer. Frontiers in Oncology. 13. 1227606–1227606. 2 indexed citations
5.
6.
Bai, Han, Shilin Xia, Lei Zhu, et al.. (2022). Altered polymerase theta expression promotes chromosomal instability in salivary adenoid cystic carcinoma. Journal of Cellular and Molecular Medicine. 26(14). 3931–3949. 1 indexed citations
7.
Shi, Xueying, et al.. (2022). Prognostic and immune-related value of STK17B in skin cutaneous melanoma. PLoS ONE. 17(2). e0263311–e0263311. 7 indexed citations
8.
Xia, Shilin, Han Liu, Nannan Wu, et al.. (2022). Heme oxygenase-1 as a predictor of sepsis-induced acute kidney injury: a cross-sectional study. Annals of Translational Medicine. 10(21). 1177–1177. 6 indexed citations
9.
10.
Lü, Xiaoli, et al.. (2021). Identification and assessment of PLK1/2/3/4 in lung adenocarcinoma and lung squamous cell carcinoma: Evidence from methylation profile. Journal of Cellular and Molecular Medicine. 25(14). 6652–6663. 13 indexed citations
11.
Zhou, Qi, Ji Li, Xueying Shi, et al.. (2021). INTS8 is a therapeutic target for intrahepatic cholangiocarcinoma via the integration of bioinformatics analysis and experimental validation. Scientific Reports. 11(1). 23649–23649. 3 indexed citations
12.
Shi, Xueying, et al.. (2021). CARD11 is a prognostic biomarker and correlated with immune infiltrates in uveal melanoma. PLoS ONE. 16(8). e0255293–e0255293. 7 indexed citations
13.
Liu, Han, Qi Zhou, Wen‐Juan Wei, et al.. (2020). The potential drug for treatment in pancreatic adenocarcinoma: a bioinformatical study based on distinct drug databases. Chinese Medicine. 15(1). 26–26. 11 indexed citations
14.
Zhou, Qi, Xufeng Tao, Shilin Xia, et al.. (2020). T Lymphocytes: A Promising Immunotherapeutic Target for Pancreatitis and Pancreatic Cancer?. Frontiers in Oncology. 10. 382–382. 34 indexed citations
15.
Zhang, Zhi, et al.. (2020). Systemic analyses of expression patterns and clinical features for GIMAPs family members in lung adenocarcinoma. Aging. 12(20). 20413–20431. 6 indexed citations
16.
Xia, Shilin, Qi Zhou, Han Liu, et al.. (2019). Emodin Attenuates Severe Acute Pancreatitis via Antioxidant and Anti-inflammatory Activity. Inflammation. 42(6). 2129–2138. 68 indexed citations
17.
18.
Wang, Guijun, Yue Wang, Yong‐sheng Teng, et al.. (2016). Protective Effects of Emodin-Induced Neutrophil Apoptosis via the Ca2+-Caspase 12 Pathway against SIRS in Rats with Severe Acute Pancreatitis. BioMed Research International. 2016. 1–9. 23 indexed citations
19.
Xiang, Hong, Guijun Wang, Jialin Qu, et al.. (2016). Yin-Chen-Hao Tang Attenuates Severe Acute Pancreatitis in Rat: An Experimental Verification of In silico Network Target Prediction. Frontiers in Pharmacology. 7. 1203–1203. 18 indexed citations
20.
Li, Shanshan, Ying Zhang, Liang Zhao, et al.. (2011). Functional analysis of promoter fragments of salt-tolerance related genes in <I>Spirulina</I>. Hereditas (Beijing). 33(10). 1134–1140. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by So‐Jin Shin Breakdown of academic impact, for papers by Shoichi Kado Breakdown of academic impact, for papers by Xufeng Guo Breakdown of academic impact, for papers by Jun Cao Breakdown of academic impact, for papers by Katarzyna Neubauer Breakdown of academic impact, for papers by Liang Shi Breakdown of academic impact, for papers by Jianwei Zhang Breakdown of academic impact, for papers by Zhenglei Xu Breakdown of academic impact, for papers by Shiyun Tan Breakdown of academic impact, for papers by Chung
Rankless by CCL
2026